These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11161132)

  • 1. Cardiovascular risk factors and the long-term outcome of lupus nephritis.
    Font J; Ramos-Casals M; Cervera R; García-Carrasco M; Torras A; Sisó A; Darnell A; Ingelmo M
    QJM; 2001 Jan; 94(1):19-26. PubMed ID: 11161132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.
    Hermansen ML; Lindhardsen J; Torp-Pedersen C; Faurschou M; Jacobsen S
    Rheumatology (Oxford); 2017 May; 56(5):709-715. PubMed ID: 28053276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
    Erre GL; Bosincu L; Faedda R; Fenu P; Masala A; Sanna M; Taras L; Longu MG; Piras M; Soro G; Satta AE; Passiu G
    Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis.
    Wong CY; Ma BMY; Zhang D; Cheung W; Chan TM; Yap DYH
    Lupus Sci Med; 2024 Mar; 11(1):. PubMed ID: 38519060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
    Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
    Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.
    Al Arfaj AS; Khalil N; Al Saleh S
    Rheumatol Int; 2009 Jul; 29(9):1057-67. PubMed ID: 19381639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.
    das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM
    Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
    Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arterial hypertension in lupus nephritis].
    Tareeva IE; Shvetsov MIu; Krasnova TN; Kutyrina IM; Nasonov EL; Kabaenkova GS; Fedorova EIu; Shilov EM
    Ter Arkh; 1997; 69(6):13-7. PubMed ID: 9297264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in patients with systemic lupus erythematosus in Colombia: a case series.
    Aguirre-Valencia D; Suárez-Avellaneda A; Ocampo-Piraquive V; Posso-Osorio I; Naranjo-Escobar J; Nieto-Aristizábal I; Tobón GJ; Cañas CA
    Clin Rheumatol; 2019 Jul; 38(7):1865-1871. PubMed ID: 30989407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
    Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
    Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid Antibodies in Lupus Nephritis.
    Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
    PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort.
    Reppe Moe SE; Molberg Ø; Strøm EH; Lerang K
    Lupus; 2019 Jun; 28(7):818-825. PubMed ID: 31072277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.
    Ward MM
    Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five consecutive years' study of renal function outcome among biopsy proven lupus nephritis patients in Southern Iran.
    Pakfetrat M; Malekmakan L; Kamranpour M; Tadayon T
    Lupus; 2017 Sep; 26(10):1082-1088. PubMed ID: 28420065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for the development of thrombotic complication in patients with lupus erythematosus and lupus nephropatic].
    Zaldívar-Alcántara H; Herrera-Jiménez LE; Dehesa-López E; Correa-Rotter R
    Rev Invest Clin; 2013; 65(3):199-208. PubMed ID: 23877806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.
    Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri S; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
    Lupus; 2019 Mar; 28(3):295-303. PubMed ID: 30700214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.